Gainers
- Zynerba Pharmaceuticals ZYNE stock increased by 301.2% to $1.36 during Monday's pre-market session. The company's market cap stands at $72.9 million.
- Taysha Gene Therapies TSHA stock rose 74.56% to $1.29. The company's market cap stands at $82.7 million.
- Virios Therapeutics VIRI shares moved upwards by 16.18% to $1.0. The company's market cap stands at $18.6 million. The company's, Q2 earnings came out 2 days ago.
- Nemaura Medical NMRD shares increased by 11.53% to $0.87. The company's market cap stands at $25.1 million.
- Trxade Health MEDS stock rose 10.29% to $9.0. The company's market cap stands at $6.1 million. As per the news, the Q2 earnings report came out today.
- Mainz Biomed MYNZ stock rose 9.55% to $3.67. The market value of their outstanding shares is at $55.9 million.
Losers
- BioXcel Therapeutics BTAI stock declined by 35.7% to $4.76 during Monday's pre-market session. The market value of their outstanding shares is at $138.7 million. As per the news, the Q2 earnings report came out today.
- Science 37 Hldgs SNCE stock decreased by 17.62% to $0.36. The market value of their outstanding shares is at $42.4 million. As per the news, the Q2 earnings report came out 4 days ago.
- PHAXIAM Therapeutics PHXM stock decreased by 13.36% to $0.48. The company's market cap stands at $29.1 million.
- Fortrea Holdings FTRE stock decreased by 11.95% to $26.98. The company's market cap stands at $2.3 billion. As per the news, the Q2 earnings report came out today.
- NovaBay Pharmaceuticals NBY shares declined by 10.49% to $0.61. The market value of their outstanding shares is at $2.5 million. As per the news, the Q2 earnings report came out 2 days ago.
- Valneva VALN stock declined by 7.82% to $13.15. The company's market cap stands at $912.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BTAIBioXcel Therapeutics Inc
$1.60-5.88%
Edge Rankings
Momentum
1.85
Growth
N/A
Quality
N/A
Value
26.67
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.